Investors

Shareholder information

The issued share capital of the Company is 33,093,415.

There are 24,978,039 B Shares in issue, none of which were held in treasury. The B Shares are in registered form, are freely transferable and there is no current offer for subscription in relation to the Company’s B Shares.

There are also 8,115,376 Ordinary Shares, none of which were held in treasury. The Ordinary Shares are in registered form, are freely transferable and there is no current offer for subscription in relation to the Company’s Ordinary Shares.

The B Share Dividend Data is as follows:

Financial Year End: 31 December

Current unaudited net asset value per share: 39.7p per B share as at 31 March 2026

Cumulative tax-free dividends paid: 21p

Dividends PaidDividend Amount
19th December 20251.5p
23rd May 20251.5p
20th December 20241.5p
17th May 20241.5p
22nd December 20231.5p
19th May 20231.5p
16th December 20221.5p
20th May 20221.5p
24th December 20211.5p
14th May 20211.5p
24th December 20201.5p
15th May 20201.5p
13th December 20191.5p
19th April 20191.5p

The Ordinary Share Dividend Data is as follows:

Financial Year End: 31 December

Current unaudited net asset value per share: 8.6p per Ordinary share as at 31 March 2026

Cumulative tax-free dividends paid: 81.3p

Please find up to date share price information for Seneca Growth Capital VCT Plc by visiting the London Stock Exchange website using the links below.

CLICK HERE: Ordinary Shares (HYG)

CLICK HERE: B Class Shares (SVCT)

You will find up to date RNS (Regulatory News Service) announcements and Market Data for Seneca Growth Capital VCT Plc by visiting the London Stock Exchange website using the link below.

Latest regulatory news

Neville Registrars Limited
Neville House,
Steelpark Rd,
Halesowen B62 8HD

View other advisers

Key dates for the offer

Year end:

31 December

Half year end:

30 June

Closing date of the offer:

5pm on 8 August 2025

Next application deadline:

Noon 7 August 2025

Reports & documents

Important notice

The contents of this website are a financial promotion and are approved by Seneca Partners Limited of 9 The Parks, Newton-le-Willows WA12 0JQ.

The value of an investment in the Seneca Capital Growth VCT plc may go down as well as up, in which case an investor may not get back the amount invested. The share prices quoted may not reflect the VCT’s net asset value.

Seneca Growth Capital VCT plc’s investments include holdings in private companies which are small and which carry an above-average level of risk to capital and whose shares may not be readily marketable. It also invests in companies quoted on the Alternative Investment Market (AIM) of the London Stock Exchange (LSE) which is generally for smaller, emerging companies and carries a higher level of risk to capital than the main market of the LSE.  The past performance of Seneca Growth Capital VCT plc is not a guide to the future performance.

Any tax reliefs available to investors are dependent on personal circumstances and may change in the future. The tax reliefs available to certain investors in Seneca Growth Capital VCT plc are dependent on the VCT maintaining Inland Revenue approval. If this approval is withdrawn, the VCT will lose its status and all tax reliefs are likely to be cancelled. Investors must retain their VCT shares for five years to retain the up-front income tax relief. The tax rules and regulations governing VCTs are subject to change.

An investment in Seneca Growth Capital VCT plc may not be suitable for all investors. Investors should seek advice from a qualified financial adviser. Nothing on this website should be construed as investment or tax advice.

Seneca Partners Ltd is authorised and regulated by the Financial Conduct Authority.

I understand

Important notice

We just want to check that you understand the risks of this investment.

Your capital is at risk and you may not get back the full amount you invested. Please confirm you have read and understood the following documents paying particular attention to the risks, before continuing:

• Prospectus
• Key information document

We recommend you speak to a financial adviser if you have any questions about the suitability of this product for you.

I understand